Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE-/- mice

Neurobiology of Aging

Volumn 31, Issue 11, 2010, Pages 1854-1866

  Austin, Susan A ^a   Combs, Colin K ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

Adhesion; Alzheimer's disease; Amyloid beta; Cardiovascular; Endothelial; Vascular

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PROTEIN TYROSINE KINASE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BRAIN BLOOD VESSEL; CELL ADHESION; CELL ASSAY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; BRAIN; CELL ADHESION; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, KNOCKOUT; MONOCYTES; SRC-FAMILY KINASES;

EID: 77956894555     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.10.013     Document Type: Article

References (73)

1. András I.E., Rha G., Huang W., Eum S., Couraud P.O., Romero I.A., Hennig B., Toborek M. Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells. Mol. Pharmacol. 2008, 73:1424-1433.
2. Attems J., Jellinger K.A. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology-a pilot study. Acta Neuropathol. (Berl) 2004, 107:83-90.
3. Attems J., Lintner F., Jellinger K.A. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol. (Berl) 2004, 107:283-291.
4. Banati R.B., Gehrmann J., Kreutzberg G.W. Glial beta-amyloid precursor protein: expression in the dentate gyrus after entorhinal cortex lesion. Neuroreport 1994, 5:1359-1361.
5. Banati R.B., Gehrmann J., Czech C., Monning U., Jones L.L., Konig G., Beyreuther K., Kreutzberg G.W. Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia. Glia 1993, 9:199-210.
6. Beher D., Hesse L., Masters C.L., Multhaup G. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I. J. Biol. Chem. 1996, 271:1613-1620.
7. Borg J.P., Ooi J., Levy E., Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 1996, 16:6229-6241.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Chalmers K., Wilcock G.K., Love S. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol. Appl. Neurobiol. 2003, 29:231-238.
10. Chromy B.A., Nowak R.J., Lambert M.P., Viola K.L., Chang L., Velasco P.T., Jones B.W., Fernandez S.J., Lacor P.N., Horowitz P., Finch C.E., Krafft G.A., Klein W.L. Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry 2003, 42:12749-12760.
11. Chung H., Brazil M.I., Soe T.T., Maxfield F.R. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J. Biol. Chem. 1999, 274:32301-32308.
12. Davies T.A., Billingslea A.M., Long H.J., Tibbles H., Wells J.M., Eisenhauer P.B., Smith S.J., Cribbs D.H., Fine R.E., Simons E.R. Brain endothelial cell enzymes cleave platelet-retained amyloid precursor protein. J. Lab. Clin. Med. 1998, 132:341-350.
13. de la Torre J.C., Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease?. Neurol. Res. 1993, 15:146-153.
14. De Meyer G.R., De Cleen D.M., Cooper S., Knaapen M.W., Jans D.M., Martinet W., Herman A.G., Bult H., Kockx M.M. Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ. Res. 2002, 90:1197-1204.
15. Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999, 354:919-920.
16. Feyt C., Pierrot N., Tasiaux B., Van Hees J., Kienlen-Campard P., Courtoy P.J., Octave J.N. Phosphorylation of APP695 at Thr668 decreases gamma-cleavage and extracellular Abeta. Biochem. Biophys. Res. Commun. 2007, 357:1004-1010.
17. Floden A.M., Li S., Combs C.K. Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J. Neurosci. 2005, 25:2566-2575.
18. Folin M., Baiguera S., Tommasini M., Guidolin D., Conconi M.T., De Carlo E., Nussdorfer G.G., Parnigotto P.P. Effects of beta-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int. J. Mol. Med. 2005, 15:929-935.
19. Forloni G., Demicheli F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain Res. 1992, 16:128-134.
20. Fryer J.D., Taylor J.W., DeMattos R.B., Bales K.R., Paul S.M., Parsadanian M., Holtzman D.M. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J. Neurosci. 2003, 23:7889-7896.
21. Fryer J.D., Simmons K., Parsadanian M., Bales K.R., Paul S.M., Sullivan P.M., Holtzman D.M. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J. Neurosci. 2005, 25:2803-2810.
22. Gianni D., Zambrano N., Bimonte M., Minopoli G., Mercken L., Talamo F., Scaloni A., Russo T. Platelet-derived growth factor induces the beta-gamma-secretase-mediated cleavage of Alzheimer's amyloid precursor protein through a Src-Rac-dependent pathway. J. Biol. Chem. 2003, 278:9290-9297.
23. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:7606-7610.
24. Gonzalez-Velasquez F.J., Moss M.A. Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. J. Neurochem. 2008, 104:500-513.
25. He X., Cooley K., Chung C.H., Dashti N., Tang J. Apolipoprotein receptor 2 and X11 alpha/beta mediate apolipoprotein E-induced endocytosis of amyloid-beta precursor protein and beta-secretase, leading to amyloid-beta production. J. Neurosci. 2007, 27:4052-4060.
26. Herzig M.C., Winkler D.T., Burgermeister P., Pfeifer M., Kohler E., Schmidt S.D., Danner S., Abramowski D., Sturchler-Pierrat C., Burki K., van Duinen S.G., Maat-Schieman M.L., Staufenbiel M., Mathews P.M., Jucker M. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 2004, 7:954-960.
27. Hirsch-Reinshagen V., Maia L.F., Burgess B.L., Blain J.F., Naus K.E., McIsaac S.A., Parkinson P.F., Chan J.Y., Tansley G.H., Hayden M.R., Poirier J., Van Nostrand W., Wellington C.L. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J. Biol. Chem. 2005, 280:43243-43256.
28. Hoe H.S., Pocivavsek A., Dai H., Chakraborty G., Harris D.C., Rebeck G.W. Effects of apoE on neuronal signaling and APP processing in rodent brain. Brain Res. 2006, 1112:70-79.
29. Hoe H.S., William Rebeck G. Functional interactions of APP with the apoE receptor family. J. Neurochem. 2008, 106:2263-2271.
30. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., Mackey B., Olney J., McKeel D., Wozniak D., Paul S.M. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2892-2897.
31. Howell B.W., Lanier L.M., Frank R., Gertler F.B., Cooper J.A. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell. Biol. 1999, 19:5179-5188.
32. Irizarry M.C., Deng A., Lleo A., Berezovska O., Von Arnim C.A., Martin-Rehrmann M., Manelli A., LaDu M.J., Hyman B.T., Rebeck G.W. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. J. Neurochem. 2004, 90:1132-1143.
33. Jahroudi N., Kitney J., Greenberger J.S., Bowser R. Endothelial cell dysfunction in response to intracellular overexpression of amyloid precursor protein. J. Neurosci. Res. 1998, 54:828-839.
34. Kalaria R.N. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1997, 826:263-271.
35. Kalaria R.N., Premkumar D.R., Pax A.B., Cohen D.L., Lieberburg I. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. Brain Res. Mol. Brain Res. 1996, 35:58-68.
36. Kibbey M.C., Jucker M., Weeks B.S., Neve R.L., Van Nostrand W.E., Kleinman H.K. beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:10150-10153.
37. Kinnecom C., Lev M.H., Wendell L., Smith E.E., Rosand J., Frosch M.P., Greenberg S.M. Course of cerebral amyloid angiopathy-related inflammation. Neurology 2007, 68:1411-1416.
38. Koldamova R., Staufenbiel M., Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem. 2005, 280:43224-43235.
39. LaDu M.J., Falduto M.T., Manelli A.M., Reardon C.A., Getz G.S., Frail D.E. Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 1994, 269:23403-23406.
40. Li L., Cao D., Garber D.W., Kim H., Fukuchi K. Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. Am. J. Pathol. 2003, 163:2155-2164.
41. Liu Q., Zerbinatti C.V., Zhang J., Hoe H.S., Wang B., Cole S.L., Herz J., Muglia L., Bu G. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 2007, 56:66-78.
42. Lorenzo A., Yuan M., Zhang Z., Paganetti P.A., Sturchler-Pierrat C., Staufenbiel M., Mautino J., Vigo F.S., Sommer B., Yankner B.A. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat. Neurosci. 2000, 3:460-464.
43. Lu D.C., Shaked G.M., Masliah E., Bredesen D.E., Koo E.H. Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann. Neurol. 2003, 54:781-789.
44. Mandybur T.I. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 1975, 25:120-126.
45. Marco S., Skaper S.D. Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci. Lett. 2006, 401:219-224.
46. Olichney J.M., Hansen L.A., Hofstetter C.R., Lee J.H., Katzman R., Thal L.J. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. Arch. Neurol. 2000, 57:869-874.
47. Premkumar D.R., Cohen D.L., Hedera P., Friedland R.P., Kalaria R.N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 1996, 148:2083-2095.
48. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C.J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., Hong Y. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171.
49. Rosendorff C., Beeri M.S., Silverman J.M. Cardiovascular risk factors for Alzheimer's disease. Am. J. Geriatr. Cardiol. 2007, 16:143-149.
50. Rossjohn J., Cappai R., Feil S.C., Henry A., McKinstry W.J., Galatis D., Hesse L., Multhaup G., Beyreuther K., Masters C.L., Parker M.W. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat. Struct. Biol. 1999, 6:327-331.
51. Russo C., Dolcini V., Salis S., Venezia V., Violani E., Carlo P., Zambrano N., Russo T., Schettini G. Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain. Ann. N. Y. Acad. Sci. 2002, 973:323-333.
52. Scheinfeld M.H., Roncarati R., Vito P., Lopez P.A., Abdallah M., D'Adamio L. Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP). J. Biol. Chem. 2002, 277:3767-3775.
53. Scheuermann S., Hambsch B., Hesse L., Stumm J., Schmidt C., Beher D., Bayer T.A., Beyreuther K., Multhaup G. Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J. Biol. Chem. 2001, 276:33923-33929.
54. Shaked G.M., Kummer M.P., Lu D.C., Galvan V., Bredesen D.E., Koo E.H. Abeta induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J. 2006, 20:1254-1256.
55. Small D.H., Clarris H.L., Williamson T.G., Reed G., Key B., Mok S.S., Beyreuther K., Masters C.L., Nurcombe V. Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. J. Alzheimers Dis. 1999, 1:275-285.
56. Soba P., Eggert S., Wagner K., Zentgraf H., Siehl K., Kreger S., Lower A., Langer A., Merdes G., Paro R., Masters C.L., Muller U., Kins S., Beyreuther K. Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO J. 2005, 24:3624-3634.
57. Sondag C.M., Combs C.K. Amyloid precursor protein mediates proinflammatory activation of monocytic lineage cells. J. Biol. Chem. 2004, 279:14456-14463.
58. Sondag C.M., Combs C.K. Amyloid precursor protein cross-linking stimulates beta amyloid production and pro-inflammatory cytokine release in monocytic lineage cells. J. Neurochem. 2006, 97:449-461.
59. Stamper H.B., Woodruff J.J. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med. 1976, 144:828-833.
60. Taru H., Yoshikawa K., Suzuki T. Suppression of the caspase cleavage of beta-amyloid precursor protein by its cytoplasmic phosphorylation. FEBS Lett. 2004, 567:248-252.
61. Trommsdorff M., Borg J.P., Margolis B., Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 1998, 273:33556-33560.
62. Van Dooren T., Muyllaert D., Borghgraef P., Cresens A., Devijver H., Van der Auwera I., Wera S., Dewachter I., Van Leuven F. Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice. Am. J. Pathol. 2006, 168:245-260.
63. Van Nostrand W.E., Melchor J.P., Keane D.M., Saporito-Irwin S.M., Romanov G., Davis J., Xu F. Localization of a fibrillar amyloid beta-protein binding domain on its precursor. J. Biol. Chem. 2002, 277:36392-36398.
64. Venezia V., Russo C., Repetto E., Salis S., Dolcini V., Genova F., Nizzari M., Mueller U., Schettini G. Apoptotic cell death influences the signaling activity of the amyloid precursor protein through ShcA and Grb2 adaptor proteins in neuroblastoma SH-SY5Y cells. J. Neurochem. 2004, 90:1359-1370.
65. Wagner M.R., Keane D.M., Melchor J.P., Auspaker K.R., Van Nostrand W.E. Fibrillar amyloid beta-protein binds protease nexin-2/amyloid beta-protein precursor: stimulation of its inhibition of coagulation factor XIa. Biochemistry 2000, 39:7420-7427.
66. Wang Y., Ha Y. The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. Mol. Cell 2004, 15:343-353.
67. Williamson T.G., Nurcombe V., Beyreuther K., Masters C.L., Small D.H. Affinity purification of proteoglycans that bind to the amyloid protein precursor of Alzheimer's disease. J. Neurochem. 1995, 65:2201-2208.
68. Xu F., Grande A.M., Robinson J.K., Previti M.L., Vasek M., Davis J., Van Nostrand W.E. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience 2007, 146:98-107.
69. Yamaguchi H., Yamazaki T., Lemere C.A., Frosch M.P., Selkoe D.J. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. Am. J. Pathol. 1992, 141:249-259.
70. Yang D.S., Smith J.D., Zhou Z., Gandy S.E., Martins R.N. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem. 1997, 68:721-725.
71. Ye S., Huang Y., Müllendorff K., Dong L., Giedt G., Meng E.C., Cohen F.E., Kuntz I.D., Weisgraber K.H., Mahley R.W. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18700-18705.
72. Zekry D., Duyckaerts C., Belmin J., Geoffre C., Moulias R., Hauw J.J. Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia. Acta Neuropathol. (Berl) 2003, 106:367-373.
73. Zhou Z., Smith J.D., Greengard P., Gandy S. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E. Mol. Med. 1996, 2:175-180.